High Flow Nasal Therapy Versus Noninvasive Ventilation in COPD Exacerbation

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 15, 2018

Primary Completion Date

March 25, 2020

Study Completion Date

April 15, 2020

Conditions
COPD Exacerbation
Interventions
OTHER

HFNT

High flow nasal therapy

OTHER

NIV

Noninvasive ventilation

Trial Locations (10)

Unknown

Ospedale S. Donato, Arezzo

Ospedale Sant'Orsola Malpighi. Università Alma Mater, Bologna

A.O.U. Policlinico-Vittorio Emanuele, Università degli Studi di Catania, Catania

Azienda Ospedaliera Universitaria Mater Domini, Catanzaro

University Hospital of Modena, Pneumology Unit and Center for Rare Lung Diseases, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena

Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone. Università degli Studi di Palermo, Palermo

IRCCS Maugeri, Pavia

Azienda Ospedaliera di Perugia, Perugia

Ospedale Molinette, Torino

Azienda Sanitaria Universitaria Integrata di Udine, Udine

All Listed Sponsors
collaborator

Azienda Ospedaliera Universitaria Mater Domini, Catanzaro

OTHER

lead

Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo

OTHER

NCT03370666 - High Flow Nasal Therapy Versus Noninvasive Ventilation in COPD Exacerbation | Biotech Hunter | Biotech Hunter